BridgeMD
New treatment option for Smoking Cessation
Official title Study to Evaluate Music Therapy and Nicotine Replacement Therapy on Craving Related to Smoking Cessation in Students
ClinicalTrials.gov ID: NCT05589220
What this study is testing
What is Nicotine replacement?
Nicotine replacement is an investigational medicine, being studied as a potential treatment for smoking cessation.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study is a randomized, controlled trial comparing music therapy associated to NRT versus NRT alone to evaluate the value of music therapy in improving the management of craving among 120 student smokers (18 to 25 years old). This pilot multi-method study will combine the methodology of clinical trials with qualitative techniques used in social sciences to show the interest of a digital music therapy tool, adapted to a young audience.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 25
You may be able to join if
- students, age \>=18 and \<=25 years,
- smoking more than 5 cigarettes per day for at least 6 months,
- motivated to quit smoking,
- without legal tutors or subordination,
- affiliated to a health insurance system as required by the French law on biomedical research,
You likely can't join if
- Roommates and couples,
- NRT contraindication
- with depression and/or psychosis and/or cognitive disorder and/or mental retardation,
- substance misuse or alcohol dependence,
- smoking-cessation medication (NRT, bupropion, varenicline) or undergoing cognitive-behavioral therapy or hypnotherapy in the last 3 months,
- electronic cigarette for smoking cessation in the last 3 months,
See the full eligibility criteria
- students, age \>=18 and \<=25 years,
- smoking more than 5 cigarettes per day for at least 6 months,
- motivated to quit smoking,
- without legal tutors or subordination,
- affiliated to a health insurance system as required by the French law on biomedical research,
- written informed consent for participation in the study.
- Roommates and couples,
- NRT contraindication
- with depression and/or psychosis and/or cognitive disorder and/or mental retardation,
- substance misuse or alcohol dependence,
- smoking-cessation medication (NRT, bupropion, varenicline) or undergoing cognitive-behavioral therapy or hypnotherapy in the last 3 months,
- electronic cigarette for smoking cessation in the last 3 months,
- Persons benefiting from enhanced protection, i.e. persons deprived of their liberty by a judicial or administrative decision, adults under legal and finally patients in a vital emergency situation.
The study team makes the final eligibility decision.
Where it's taking place
- Poitiers, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Poitiers, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.